RNA Stock Analysis: Buy, Sell, or Hold?
RNA - Avidity Biosciences, Inc. Common Stock
$12.95
-0.28 (-2.12%)
▼
5d:
-2.26%
30d:
-10.13%
90d:
-82.23%
BUY
HIGH Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When RNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: RNA is currently trading at $12.95, which is considered slightly low relative to its 30-day fair value range of $12.85 to $13.89.
Technical Outlook: Technically, RNA is in a strong downtrend. The price is currently testing key support at $12.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+89.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RNA is in a strong downtrend. The price is currently testing key support at $12.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+89.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$12.85 -
$13.89
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 89.0% below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$12.85 -
$13.89
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$12.75
Resistance Level
$13.97
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.86
Wall Street Target
$25.00
(+89.0%)
Revenue Growth (YoY)
-71.1%
Profit Margin
-265.9%
Share & Embed Analysis
Last updated: May 18, 2026 4:22 PM ET
Data refreshes hourly during market hours. Next update: 5:22 PM
Data refreshes hourly during market hours. Next update: 5:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael F Maclean
SELL
4542 shares
2026-01-21
Arthur A Levin
SELL
1758 shares
2026-01-21
W. Michael Flanagan
SELL
6534 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 45 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 50 HOLD |
Advanced RNA Option Strategies
Professional options setups generated by AI based on today's RNA price and gamma walls.
